Mehiläinen concludes the acquisition of Romania's Regina Maria and Serbia's MediGroup, expanding its footprint in the private healthcare sector.

Target Overview

Mehiläinen has successfully concluded its acquisition of Regina Maria and MediGroup, leading healthcare providers in Romania and Serbia, respectively. The necessary regulatory approvals were obtained, and the deals were finalized on December 18, 2025. Regina Maria serves over 2 million customers annually, offering extensive medical center and hospital services, while MediGroup is the leading private healthcare operator in Serbia, known for its high-quality care and commitment to healthcare development.

Regina Maria stands out as Romania's top medical quality provider, boasting five internationally accredited hospitals and 22 accreditations—the highest achievement in Central and Eastern Europe, demonstrating their commitment to medical excellence and patient safety. Over the past decade, more than one million feedback responses have been collected for their medical professionals, resulting in an impressive average score of 9.63.

Industry Overview

The healthcare sector in Romania is undergoing significant transformation, driven by increased demand for high-quality medical services. With a population increasingly prioritizing health and wellness, private healthcare provi

View Source

Similar Deals

大昌華嘉 德怡科技與量子生物科技

2025

Buyout Biotechnology & Medical Research (NEC) Other
SK Capital Swixx Biopharma

2025

Buyout Biopharmaceuticals Other
大昌華嘉 德怡科技及量子生物科技

2025

Buyout Biotechnology & Medical Research (NEC) Other
DKSH Taqkey Science and Quantum Biotech

2025

Buyout Biotechnology & Medical Research (NEC) Other
DKSH Taqkey and Quantum

2025

Buyout Pharmaceuticals Wholesale Other
TELUS Health HUMANOO

2024

Buyout Healthcare Facilities & Services (NEC) Other

Mehiläinen

invested in

Regina Maria and MediGroup

in 2025

in a Buyout deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert